ciprofloxacin has been researched along with Arterial Occlusive Diseases in 1 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joukhadar, C | 1 |
| Klein, N | 1 |
| Frossard, M | 1 |
| Minar, E | 1 |
| Stass, H | 1 |
| Lackner, E | 1 |
| Herrmann, M | 1 |
| Riedmüller, E | 1 |
| Müller, M | 1 |
1 trial available for ciprofloxacin and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Angioplasty increases target site concentrations of ciprofloxacin in patients with peripheral arterial occlusive disease.
Topics: Adipose Tissue; Aged; Aged, 80 and over; Angioplasty; Anti-Infective Agents; Area Under Curve; Arter | 2001 |